Great news about funds even we do miss out on the options....IMO Cantrixil has always been 2015 be it Q3/Q4 due to gaining Orphan Drug designation, too many people read 2016 about the other drug pipelines.
Its been on their website for sometime now that they wanted to have trials starting in Q3 2015
@Pbnewby I still think it quiet possible to announce major developments on the BBB Friday NY time without breaking ASX disclosure rules and this raise, unlike Decembers is well planned with a great news flow so I would hope that they knew that results from testing would flow around the time of a cap raise!
NRT Price at posting:
29.5¢ Sentiment: Hold Disclosure: Held
